308 related articles for article (PubMed ID: 11756161)
21. Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.
Kawagoe H; Grosveld GC
Blood; 2005 Dec; 106(13):4269-77. PubMed ID: 16105979
[TBL] [Abstract][Full Text] [Related]
22. Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice.
Lin CC; Yao CY; Hsu YC; Hou HA; Yuan CT; Li YH; Kao CJ; Chuang PH; Chiu YC; Chen Y; Chou WC; Tien HF
Oncogene; 2020 Jul; 39(28):5112-5123. PubMed ID: 32533098
[TBL] [Abstract][Full Text] [Related]
23. The PAF1c Subunit CDC73 Is Required for Mouse Hematopoietic Stem Cell Maintenance but Displays Leukemia-Specific Gene Regulation.
Saha N; Ropa J; Chen L; Hu H; Mysliwski M; Friedman A; Maillard I; Muntean AG
Stem Cell Reports; 2019 May; 12(5):1069-1083. PubMed ID: 31031188
[TBL] [Abstract][Full Text] [Related]
24. A crucial role for the homeodomain transcription factor Hhex in lymphopoiesis.
Jackson JT; Nasa C; Shi W; Huntington ND; Bogue CW; Alexander WS; McCormack MP
Blood; 2015 Jan; 125(5):803-14. PubMed ID: 25472970
[TBL] [Abstract][Full Text] [Related]
25. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
Jankovic D; Gorello P; Liu T; Ehret S; La Starza R; Desjobert C; Baty F; Brutsche M; Jayaraman PS; Santoro A; Mecucci C; Schwaller J
Blood; 2008 Jun; 111(12):5672-82. PubMed ID: 18388181
[TBL] [Abstract][Full Text] [Related]
26. Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer.
Clay TM; Custer MC; Spiess PJ; Nishimura MI
Pathol Oncol Res; 1999; 5(1):3-15. PubMed ID: 10079371
[TBL] [Abstract][Full Text] [Related]
27. Transplantable cell lines generated with NUP98-Hox fusion genes undergo leukemic progression by Meis1 independent of its binding to DNA.
Pineault N; Abramovich C; Humphries RK
Leukemia; 2005 Apr; 19(4):636-43. PubMed ID: 15744344
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo.
Yu H; Neale G; Zhang H; Lee HM; Ma Z; Zhou S; Forget BG; Sorrentino BP
Blood; 2014 Sep; 124(11):1737-47. PubMed ID: 25082879
[TBL] [Abstract][Full Text] [Related]
29. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
30. Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations.
Dorrance AM; Liu S; Yuan W; Becknell B; Arnoczky KJ; Guimond M; Strout MP; Feng L; Nakamura T; Yu L; Rush LJ; Weinstein M; Leone G; Wu L; Ferketich A; Whitman SP; Marcucci G; Caligiuri MA
J Clin Invest; 2006 Oct; 116(10):2707-16. PubMed ID: 16981007
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system.
Mayotte N; Roy DC; Yao J; Kroon E; Sauvageau G
Blood; 2002 Dec; 100(12):4177-84. PubMed ID: 12393433
[TBL] [Abstract][Full Text] [Related]
32. Mapping of MN1 sequences necessary for myeloid transformation.
Kandilci A; Surtel J; Janke L; Neale G; Terranova S; Grosveld GC
PLoS One; 2013; 8(4):e61706. PubMed ID: 23626719
[TBL] [Abstract][Full Text] [Related]
33. Hoxa9 transduction induces hematopoietic stem and progenitor cell activity through direct down-regulation of geminin protein.
Ohno Y; Yasunaga S; Janmohamed S; Ohtsubo M; Saeki K; Kurogi T; Mihara K; Iscove NN; Takihara Y
PLoS One; 2013; 8(1):e53161. PubMed ID: 23326393
[TBL] [Abstract][Full Text] [Related]
34. Ectopic expression of Delta4 impairs hematopoietic development and leads to lymphoproliferative disease.
Dorsch M; Zheng G; Yowe D; Rao P; Wang Y; Shen Q; Murphy C; Xiong X; Shi Q; Gutierrez-Ramos JC; Fraser C; Villeval JL
Blood; 2002 Sep; 100(6):2046-55. PubMed ID: 12200365
[TBL] [Abstract][Full Text] [Related]
35. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis.
Lawrence HJ; Helgason CD; Sauvageau G; Fong S; Izon DJ; Humphries RK; Largman C
Blood; 1997 Mar; 89(6):1922-30. PubMed ID: 9058712
[TBL] [Abstract][Full Text] [Related]
36. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.
Kawagoe H; Humphries RK; Blair A; Sutherland HJ; Hogge DE
Leukemia; 1999 May; 13(5):687-98. PubMed ID: 10374871
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.
Somervaille TC; Cleary ML
Cancer Cell; 2006 Oct; 10(4):257-68. PubMed ID: 17045204
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A
Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018
[TBL] [Abstract][Full Text] [Related]
39. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
Calvo KR; Sykes DB; Pasillas MP; Kamps MP
Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
[TBL] [Abstract][Full Text] [Related]
40. Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells.
Gil-Kulik P; Dudzińska E; Radzikowska-Büchner E; Wawer J; Jojczuk M; Nogalski A; Wawer GA; Feldo M; Kocki W; Cioch M; Bogucka-Kocka A; Rahnama M; Kocki J
BMC Cancer; 2020 May; 20(1):435. PubMed ID: 32423430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]